ProShare Advisors’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Buy
+5,240
New +$298K ﹤0.01% 1306
2026
Q1
Sell
-3,467
Closed -$451K 2039
2025
Q4
$451K Buy
3,467
+257
+8% +$35.3K ﹤0.01% 1187
2025
Q3
$346K Sell
3,210
-640
-17% -$69.7K ﹤0.01% 1325
2025
Q2
$355K Buy
3,850
+1,083
+39% +$85K ﹤0.01% 1334
2025
Q1
$245K Sell
2,767
-831
-23% -$72.1K ﹤0.01% 1554
2024
Q4
$277K Buy
+3,598
New +$251K ﹤0.01% 1691
2023
Q2
Sell
-1,055
Closed -$12.7K 1912
2023
Q1
$12.7K Buy
1,055
+439
+71% +$5.85K ﹤0.01% 1757
2022
Q4
$5.37K Buy
616
+88
+17% +$1.94K ﹤0.01% 1843
2022
Q3
$15K Sell
528
-10
-2% -$458 ﹤0.01% 1727
2022
Q2
$22K Buy
+538
New +$36.5K ﹤0.01% 1760

Other funds holding WGS

ProShare Advisors's WGS Position: Q2 2026 in Review

ProShare Advisors opened a new position in GeneDx Holdings (WGS) in Q2 2026: 5,240 shares worth $360K. The stake represents ﹤0.01% of the portfolio and ranks #1306 among its holdings. This is a return to the name: ProShare Advisors previously reported a position in WGS as recently as Q4 2025.

ProShare Advisors first reported a position in WGS in Q2 2022 and has held it in 10 quarters since. The position peaked at $451K in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • ProShare Advisors held 5,240 shares of GeneDx Holdings worth $360K as of Q2 2026.
  • GeneDx Holdings was a new ProShare Advisors position in Q2 2026.
  • GeneDx Holdings made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1306 holding.
  • ProShare Advisors first reported a position in GeneDx Holdings in Q2 2022 and has held it in 10 quarters since.
  • ProShare Advisors's GeneDx Holdings position peaked at $451K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.